With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG)||Baylor College of Medicine / Nabil Ahmed, MD, MSc||Innovation Grants||2013||Texas|
|Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells||Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D.||Bio-Therapeutic Impact Award||2014||Texas|
|Dissecting and Targeting the Wnt Signaling Pathway in Metastatic Osteosarcoma||Baylor College of Medicine / Jason T. Yustein, MD, PhD||Young Investigator Grants||2013||Texas|
|Elucidating the Mechanism of ERK Mediated Pathogenesis of LCH||Baylor College of Medicine / Rikhia Chakraborty, PhD||Young Investigator Grants||2015||Texas|
|Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene||Baylor College of Medicine / Robin Parihar, MD, PhD||Young Investigator Grants||2015||Texas|
|Genetically Engineered T Cells as Therapy for Pediatric Glioma||Baylor College of Medicine / Giedre Krenciute, PhD||Young Investigator Grants||2016||Texas|
|Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence||Baylor College of Medicine / Stacey Berg, MD - Scholars: Jennifer Foster, MD, MPH and Ron Bernardi, MD,PhD||Center of Excellence Grants||2012||Texas|
|V alpha-invariant NKT cells as a novel platform for cancer immunotherapy||Baylor College of Medicine / Leonid Metelitsa, MD, PhD||Innovation Grants||2012||Texas|
|Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies||Baylor College of Medicine / Stephen Gottschalk, MD||Innovation Grants||2013||Texas|
|Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma||Baylor College of Medicine / Cliona Rooney, PhD||Reach Grants||2013||Texas|